Introduction: Acquired brain injury (ABI) during childhood typically causes behavior problems in the child and high levels of stress in the family. The aims of this study are: (1) to investigate the effectiveness and feasibility of a parenting intervention in improving behavior and self-regulation in Mexican children with ABI compared to telephone support; (2) to investigate the effectiveness and feasibility of a parenting intervention in improving parenting skills, parent self-efficacy and decreasing parental stress in parents of children with ABI compared to telephone support. Our secondary aims are (1) to explore the impact that parent characteristics have on the intervention outcomes; (2) to investigate if changes are maintained 3 months after the intervention. Methods: The research design is a blind randomized controlled trial (RCT). Eligible participants include children with a diagnosis of ABI, between 6 and 12 years of age, and their parents. Sixty-six children and their parents will be randomly allocated to either a parenting program group or telephone support group. The parenting program involves six face-to-face weekly group sessions of 2.5 h each. Participants in the control group receive an information sheet with behavioral strategies, and six weekly phone calls, in which strategies to improve academic skills are provided. Children and their parents are evaluated by blind assessors before the intervention, immediately after the intervention and 3-months post-intervention. Discussion: This study will be the first to evaluate the efficacy and feasibility of a parenting program for Mexican parents of children with ABI.

, , , ,
doi.org/10.1016/j.conctc.2017.06.007, hdl.handle.net/1765/123633
Contemporary Clinical Trials Communications

Chavez Arana, C.L., Catroppa, C., Hearps, S., Yanez-Tellez, G., Prieto-Corona, B., De Leon-Miranda, M., … Anderson, V. (2017). Parenting program versus telephone support for Mexican parents of children with acquired brain injury: A blind randomized controlled trial. Contemporary Clinical Trials Communications, 7, 109–115. doi:10.1016/j.conctc.2017.06.007